BANK OF AMERICA CORP /DE/ - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 48 filers reported holding REPROS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$16,000
-5.9%
24,992
-53.3%
0.00%
Q3 2017$17,000
-34.6%
53,475
-4.7%
0.00%
Q2 2017$26,000
-52.7%
56,087
+22.3%
0.00%
Q1 2017$55,000
+7.8%
45,876
+18.5%
0.00%
Q4 2016$51,000
-40.0%
38,725
-5.1%
0.00%
Q3 2016$85,000
+30.8%
40,810
+1.1%
0.00%
Q2 2016$65,000
+20.4%
40,364
-28.0%
0.00%
Q1 2016$54,000
-12.9%
56,094
+8.8%
0.00%
Q4 2015$62,000
-97.8%
51,551
-86.4%
0.00%
-100.0%
Q3 2015$2,822,000
-24.4%
379,797
-27.3%
0.00%0.0%
Q2 2015$3,734,000
+18.7%
522,274
+42.7%
0.00%0.0%
Q1 2015$3,145,000
-8.9%
366,088
+5.7%
0.00%0.0%
Q4 2014$3,453,000
+11.2%
346,316
+10.4%
0.00%0.0%
Q3 2014$3,106,000
-25.9%
313,725
+29.4%
0.00%0.0%
Q2 2014$4,194,000
+14.2%
242,395
+17.1%
0.00%0.0%
Q1 2014$3,672,000
+56.6%
207,015
+61.6%
0.00%0.0%
Q4 2013$2,345,000
-74.2%
128,096
-62.3%
0.00%
-66.7%
Q3 2013$9,098,000
-15.6%
339,448
-41.9%
0.00%
-25.0%
Q2 2013$10,781,000584,3090.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 978,800$1,292,0000.33%
Allegis Investment Advisors, LLC 344,487$455,0000.14%
GENERAL AMERICAN INVESTORS CO INC 589,768$778,0000.08%
Acrospire Investment Management LLC 23,177$31,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 268,130$354,0000.01%
Alambic Investment Management, L.P. 16,091$21,0000.00%
OXFORD ASSET MANAGEMENT LLP 51,359$68,0000.00%
Renaissance Technologies 716,413$946,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 2,700$4,0000.00%
Virtu KCG Holdings LLC 45,144$60,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders